Predictive value of serum HBcrAg in antiviral therapy for chronic hepatitis B. [PDF]
Wang S +12 more
europepmc +1 more source
Dynamics of Anti-HBc Serology During Anti-CD20 Therapy: Incidence, Timing, and Predictors of Anti-HBc Seroclearance in a Retrospective Cohort. [PDF]
Eren F +6 more
europepmc +1 more source
Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients. [PDF]
Kita Y +11 more
europepmc +1 more source
Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity. [PDF]
Yılmaz Gürbüz Ş +2 more
europepmc +1 more source
Hepatitis C virus-associated B-cell non-Hodgkin lymphomas: immune evasion, multistep lymphomagenesis, and candidate biomarkers for risk stratification and disease monitoring. [PDF]
Carloni G, Ponzetto A, Rinaldi M.
europepmc +1 more source
Immune checkpoints: cross-disease insights and clinical dilemmas. [PDF]
Shu Y +7 more
europepmc +1 more source
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. [PDF]
Kerth HA +15 more
europepmc +1 more source
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral Protein Degradation. [PDF]
Pan MY +11 more
europepmc +1 more source
Association of baseline HBcAg and HBV DNA with persistent detectability of HBV RNA during NA therapy. [PDF]
Wu L +10 more
europepmc +1 more source
A tangible and interactive viral model for enhancing virology education: using hepatitis B virus as a model system. [PDF]
Li J, Zhang L.
europepmc +1 more source

